Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

RadNet, Inc.

RDNT•NASDAQ
Healthcare
Medical - Diagnostics & Research
$70.50
$0.00(0.00%)
U.S. Market is Open • 12:58

RadNet, Inc. (RDNT) Stock Overview

Explore RadNet, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.4B
P/E Ratio-411.23
EPS (TTM)$-0.16
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$55.93
3 Months$60.67
1 Year Target$94.24

RDNT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of RadNet, Inc. (RDNT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $94.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -411.23 and a market capitalization of 5.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.60%
5-Day Change
7.34%
1-Month Change
-0.53%
3-Month Change
-11.58%
6-Month Change
2.10%
Year-to-Date (YTD) Change
-1.23%
1-Year Change
11.82%
3-Year Change
231.82%
5-Year Change
276.57%
All-Time (Max) Change
9370.27%

Contact Information

https://www.radnet.com
310 478 7808
1508, 1510 and 1516 Cotner Avenue, Los Angeles, CA, 90025-3303

Company Facts

110,000 Employees
IPO DateJan 3, 1997
CountryUS
Actively Trading

Frequently Asked Questions